sulphasalazine ( sasp ) has recently become established as an effective treatment for active rheumatoid arthritis ( ra ) , but has not previously been used in psoriatic arthritis in which remission-inducing drugs have proved disappointing .
C0036078
sulphasalazine
C0003873
rheumatoid arthritis